Dr. Handoo of Kansas City Psychiatry Partners has been a pioneer in the local medical community, offering intravenous ketamine treatments since 2016. As one of the first 300 physicians in the United States to adopt this method, he has overseen more than 8,000 individual sessions over the last decade.
His contributions to the field earned him a position on the Expert Faculty of the American Society of Ketamine Physicians, an organization that restricts this specific designation to only 25 doctors nationwide. This clinical approach focuses on providing relief where traditional methods may have fallen short.
In a recent feature, we looked at the experiences of patients who undergo this protocol. One participant, a 46-year-old woman named Lisa, completed a series of six sessions four years ago. She reports significant improvements in her overall well-being since that time.
Interested parties can find more information about these medical services at the Kansas City Psychiatry Partners website or the personal site for Dr. Handoo.